Simplex Realty (503229)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹155.55 |
| Market Cap | ₹47.46 Cr |
| P/E Ratio | 0 |
| ROCE | 2.32% |
| ROE | -1.68% |
| Dividend Yield | 0% |
| Profit Growth | -176.6% |
| Debt/Equity | — |
| Sales Growth | -19.23% |
| 52-Week Range | ₹117.7 — ₹191.8 |
| Sector | Realty |
| Book Value | ₹367.81 |
Strengths
- Price-to-book of 0.42 means the market prices the stock at a 58% discount to stated book value of ₹367.81 per share.
- Market cap is only ₹47 Cr, so a single meaningful asset sale could have an outsized impact.
- ROCE is positive at 2.32%, suggesting the existing capital base is not completely value-destructive on that metric.
- The company is not burdened by current dividend obligations, allowing retained assets to potentially be monetised.
Concerns
- Latest quarter sales are ₹0 Cr and net profit is ₹-0 Cr, indicating no active operating earnings.
- Profit growth of -176.60% and ROE of -1.68% mean book value is being eroded.
- Piotroski F-Score of 3/9 points to weak financial health and possible balance-sheet stress.
- Debt/equity and promoter holding are N/A, leaving critical due diligence questions unanswered.
AI Analysis
Simplex Realty presents the kind of cigar-butt setup Graham liked, but I must apply the same caution he did. The obvious attraction is valuation: price ₹155.55, book value ₹367.81, so P/B is 0.42. I am paying only 42 paise for one rupee of stated net assets; with a market cap of ₹47 Cr, the asset cushion appears substantial. However, price alone doesn't create value. This is where I pause. The latest quarter shows sales ₹0 Cr and net profit ₹-0 Cr. Sales growth is -19.23%, and profit growth is -176.60%. ROE is -1.68%, so the book value I am buying is slowly being eroded. ROCE at 2.32% is barely positive, but with no revenue, operating returns are meaningless. The P/E is 0.00, which is not a bargain signal; it tells me there are no earnings to justify a multiple. The Piotroski F-Score of 3/9 reinforces the poor health of the business. There is no dividend yield, so I get no income while waiting for a catalyst. Debt-to-equity and promoter holding are listed as N/A, so I cannot certify the balance-sheet risks or management alignment. In a real asset play, I need to know the land's realizable value, the cost to carry it, and whether management is incentivized to unlock it. Without those answers, the discount to book may be a permanent discount. If Simplex can eventually sell or develop its real estate and convert asset value into cash, the upside is large. But I am not a buyer today on these numbers alone. I would place it on the watchlist and wait for tangible operating or transaction evidence. That is the Buffett-Graham way: buy a good asset cheaply, but only when the facts support the value.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer